178 results on '"El-Hachem, Nehme"'
Search Results
2. A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses
3. CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
4. The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
5. UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells
6. Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice
7. Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal
8. Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth.
9. Forced Intracellular Degradation of Xenoantigens: A Novel Modality for Cell-Based Cancer Immunotherapy
10. Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors
11. CBFA2T3::GLIS2 Pediatric Acute Megakaryoblastic Leukemia is Sensitive to BCL-XL Inhibition by Navitoclax and DT2216
12. Data from TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
13. Supplementary Data from TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
14. gem-Difluorobisarylic derivatives: design, synthesis and anti-inflammatory effect
15. Genetic pathway analysis reveals a major role for extracellular matrix organization in inflammatory and neuropathic pain
16. Supplementary Table 5 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
17. Supplementary Table 3 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
18. Supplementary Table 1 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
19. Data from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
20. Supplementary Table 4 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
21. Supplementary Methods from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
22. Supplementary Table 2 from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
23. Supplementary Figures from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
24. Supplementary Table Legends from Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
25. Dataset: Assessment of pharmacogenomic agreement
26. Tissue specificity of in vitro drug sensitivity
27. AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study
28. Safikhani et al. reply
29. Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening
30. LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress Response
31. Acute inflammatory response via neutrophil activation protects against the development of chronic pain
32. Additional file 1 of UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells
33. Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
34. The CIt Protocol: A Blueprint to Potentiate the Immunogenicity of Immunoproteasome-Reprogrammed Mesenchymal Stromal Cells
35. Identification of new GATA4-small molecule inhibitors by structure-based virtual screening
36. Bioexploration and Phylogenetic Placement of Entomopathogenic Fungi of the Genus Beauveria in Soils of Lebanon Cedar Forests
37. Inconsistency in large pharmacogenomic studies
38. Um171A-Induced Ros Promote Antigen Cross-Presentation Of Immunogenic Peptides By Bone Marrow-Derived Mesenchymal Stromal Cells
39. Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivo
40. New analogues of 13-hydroxyocatdecadienoic acid and 12-hydroxyeicosatetraenoic acid block human blood platelet aggregation and cyclooxygenase-1 activity
41. Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells
42. Engineering a Potent Cancer Vaccine Using Immunoproteasome-Expressing Mesenchymal Stromal Cells
43. TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
44. Assessment of Genetic Drift in Large Pharmacogenomic Studies
45. mRMRe: an R package for parallelized mRMR ensemble feature selection
46. Exosomal miRNA Profiling in Lebanese Multiple Sclerosis Patients.
47. A comparison of artificial intelligence-based algorithms for the identification of patients with depressed right ventricular function from 2-dimentional echocardiography parameters and clinical features
48. Integrative transcriptome analyses empower the anti-COVID-19 drug arsenal
49. A novelTRAF3IP2variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans
50. A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.